Pluri

(NASDAQ) PLUR

Current Price$3.30

Market Cap$33.17M

Since IPO (2003)-100%

5 Year-90%

1 Year-32%

1 Month+1%

Pluri Financials at a Glance

Market Cap

$33.17M

Revenue (TTM)

$1.34M

Net Income (TTM)

$26.14M

EPS (TTM)

$-3.26

P/E Ratio

-1.01

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$3.30

Volume

18,300.442

Open

$3.35

Price

$3.30

Volume

18,300.442

Open

$3.35

Previous Close

$3.30

Daily Range

$3.20 - $3.47

52-Week Range

$2.82 - $6.10

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$3.30

Volume

18,300.442

Open

$3.35

Previous Close

$3.30

Daily Range

$3.20 - $3.47

52-Week Range

$2.82 - $6.10

PLUR News

Are Stem Cells the COVID-19 Treatment We've All Been Waiting For?

Maxx ChatskoApr 28, 2020

Here's Why Pluristem Therapeutics Jumped Over 28% Today

Maxx ChatskoApr 24, 2020

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Leo SunNov 13, 2013

Why Pluristem Therapeutics Is Poised to Plunge

BRIAN PACAMPARAJan 16, 2013

3 Horrendous Health-Care Stocks This Week

Keith SpeightsDec 29, 2012

Are Short-Sellers Onto Something at Pluristem Therapeutics?

Rich DupreyNov 29, 2012

This Week in Biotech: Part 2

Sean WilliamsNov 10, 2012

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pluri

Industry

Biotechnology

Sector

Health Care

Employees

127

CEO

Yaky Yanay, CPA

Website

www.pluri-biotech.com

Headquarters

Haifa, 3508409, IL

PLUR Financials

Key Financial Metrics (TTM)

Gross Margin

21%

Operating Margin

-19%

Net Income Margin

-20%

Return on Equity

Return on Capital

14%

Return on Assets

-85%

Earnings Yield

-99.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.17M

Shares Outstanding

10.05M

Volume

18.30K

Avg. Volume

6.41K

Financials (TTM)

Gross Profit

$654.00K

Operating Income

$22.18M

EBITDA

$22.07M

Operating Cash Flow

$18.21M

Capital Expenditure

$1.62M

Free Cash Flow

$19.83M

Cash & ST Invst.

$20.61M

Total Debt

$34.05M

Pluri Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$198.00K

+7.0%

Gross Profit

$43.00K

-138.7%

Gross Margin

-21.72%

N/A

Market Cap

$33.17M

N/A

Market Cap/Employee

$312.90K

N/A

Employees

106

N/A

Net Income

$6.54M

-121.3%

EBITDA

$6.38M

-125.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$28.08M

-251.7%

Accounts Receivable

$169.00K

+20.7%

Inventory

$0.00

N/A

Long Term Debt

$12.29M

-57.2%

Short Term Debt

$28.49M

+4688.9%

Return on Assets

-85.43%

N/A

Return on Invested Capital

14.22%

N/A

Free Cash Flow

$5.65M

-19.2%

Operating Cash Flow

$5.21M

-12.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.58+0.64%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.80+3.26%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$10.72+15.02%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.77+9.94%

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.95-2.02%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$6.00-3.54%

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$5.21+0.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

NOKNokia

NOKNokia$13.19-0.02%

ERNAErnexa Therapeutics

ERNAErnexa Therapeutics$6.04+0.51%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.59-0.06%

SNAPSnap

SNAPSnap$6.11+0.33%

PLTRPalantir Technologies

PLTRPalantir Technologies$133.79-0.02%

Questions About PLUR

What is the current price of Pluri?

Pluri is trading at $3.30 per share.

What is the 52-week range for Pluri?

Over the past 52 weeks, Pluri has traded between $2.82 and $6.10.

How much debt does Pluri have?

As of the most recent reporting period, Pluri reported total debt of $34.64M.

How much cash does Pluri have on hand?

Pluri reported $4.91M in cash and cash equivalents in its most recent financial results.

What is Pluri’s dividend yield?

Pluri does not currently have a dividend yield.

Pluri

Pluri Financials at a Glance

PLUR News

Are Stem Cells the COVID-19 Treatment We've All Been Waiting For?

Here's Why Pluristem Therapeutics Jumped Over 28% Today

Top Stories in Biotech This Morning: Pluristem Therapeutics, Inc, Rigel Pharmaceuticals, Inc. and Sangamo Biosciences, Inc.

Why Sinovac, Pluristem, and Synta Could Be Worth Watching Today

Why Pluristem Therapeutics Is Poised to Plunge

3 Horrendous Health-Care Stocks This Week

Are Short-Sellers Onto Something at Pluristem Therapeutics?

This Week in Biotech: Part 2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pluri

PLUR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pluri Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PLUR

What is the current price of Pluri?

What is the 52-week range for Pluri?

How much debt does Pluri have?

How much cash does Pluri have on hand?

What is Pluri’s dividend yield?

Premium Investing Services